These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32550595)

  • 21. Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A.
    Miyashita SI; Karatsu S; Fujiishi M; Huang IH; Nagashima Y; Morobishi T; Hosoya K; Hata T; Dong M; Sagane Y
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabrication, characterization and evaluation of a new designed botulinum toxin-cell penetrating peptide nanoparticulate complex.
    Ravari NS; Sheikhlou MG; Goodarzi N; Kharazian B; Amini M; Atyabi F; Nasrollahi SA; Dinarvand R
    Daru; 2023 Jun; 31(1):1-12. PubMed ID: 37209247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ouabain exacerbates botulinum neurotoxin-induced muscle paralysis via progression of muscle atrophy in mice.
    Fujikawa R; Muroi Y; Unno T; Ishii T
    J Toxicol Sci; 2010 Dec; 35(6):795-805. PubMed ID: 21139329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic efficacy of new botulinum toxin identified in CCUG 7968 strain.
    An Y; Kim YJ; Kim CS; Yim H; Kim M; Lee EK; Oh HJ; Han JH; Yoo E; Kim S; Woo J; Moore ERB; Jung JY; Park W
    Appl Microbiol Biotechnol; 2021 Dec; 105(23):8727-8737. PubMed ID: 34716460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing toxin-based vaccines against botulism.
    Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT
    Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum neurotoxin X lacks potency in mice and in human neurons.
    Gregg BM; Matsumura T; Wentz TG; Tepp WH; Bradshaw M; Stenmark P; Johnson EA; Fujinaga Y; Pellett S
    mBio; 2024 Mar; 15(3):e0310623. PubMed ID: 38347673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Systemic Toxicity between Botulinum Toxin Subtypes A1 and A2 in Mice and Rats.
    Torii Y; Goto Y; Nakahira S; Kozaki S; Kaji R; Ginnaga A
    Basic Clin Pharmacol Toxicol; 2015 Jun; 116(6):524-8. PubMed ID: 25395371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S; Bradshaw M; Tepp WH; Pier CL; Whitemarsh RCM; Chen C; Barbieri JT; Johnson EA
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is spastic muscle echo intensity related to the response to botulinum toxin type A in patients with stroke? A cohort study.
    Picelli A; Bonetti P; Fontana C; Barausse M; Dambruoso F; Gajofatto F; Girardi P; Manca M; Gimigliano R; Smania N
    Arch Phys Med Rehabil; 2012 Jul; 93(7):1253-8. PubMed ID: 22502807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate cleavage and duration of action of botulinum neurotoxin type FA ("H, HA").
    Pellett S; Tepp WH; Lin G; Johnson EA
    Toxicon; 2018 Jun; 147():38-46. PubMed ID: 29273248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different types of botulinum toxin in humans.
    Eleopra R; Tugnoli V; Quatrale R; Rossetto O; Montecucco C
    Mov Disord; 2004 Mar; 19 Suppl 8():S53-9. PubMed ID: 15027055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin.
    Adler M; Macdonald DA; Sellin LC; Parker GW
    Toxicon; 1996 Feb; 34(2):237-49. PubMed ID: 8711757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced Effect of Botulinum Toxin A Injections into the Extensor Digitorum Brevis Muscle after Local Mechanical Leg Vibration: A Case Report.
    Hefter H; Beek J; Rosenthal D; Samadzadeh S
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34203875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of a novel subtype a3 botulinum neurotoxin.
    Tepp WH; Lin G; Johnson EA
    Appl Environ Microbiol; 2012 May; 78(9):3108-13. PubMed ID: 22367089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of treadmill therapy on neuromuscular atrophy induced via botulinum toxin A.
    Tsai SW; Chen HL; Chang YC; Chen CM
    Neural Plast; 2013; 2013():593271. PubMed ID: 24327926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.
    Eleopra R; Tugnoli V; Rossetto O; De Grandis D; Montecucco C
    Neurosci Lett; 1998 Nov; 256(3):135-8. PubMed ID: 9855358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response.
    Dolimbek BZ; Jankovic J; Atassi MZ
    Immunol Invest; 2002; 31(3-4):247-62. PubMed ID: 12472183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.
    Miethe S; Rasetti-Escargueil C; Liu Y; Chahboun S; Pelat T; Avril A; Frenzel A; Schirrmann T; Thullier P; Sesardic D; Hust M
    MAbs; 2014; 6(2):446-59. PubMed ID: 24492304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse compound muscle action potential assay: an alternative method to conduct the LD₅₀ botulinum toxin type A potency test.
    Kim SH; Kim SB; Yang GH; Rhee CH
    Toxicon; 2012 Sep; 60(3):341-7. PubMed ID: 22613167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.